CoChat

Sampling of Major Histocompatibility Complex Class I-Associated Peptidome Suggests Relatively Looser Global Association of HLA-B*5101 With Peptides

Gebreselassie, Daniel, Spiegel, Hans, Vukmanovic, Stanislav · 2006 · Human Immunology
Cited by 29

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.humimm.2006.08.294

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 38

  1. Pamer, 1998, Mechanisms of MHC class I–restricted antigen processing, Annu Rev Immunol, 16, 323, 10.1146/annurev.immunol.16.1.323 · DOI · Paper page
  2. Engelhard, 1994, Structure of peptides associated with class I and class II MHC molecules, Ann Rev Immunol, 12, 181, 10.1146/annurev.iy.12.040194.001145 · doi:10.1146/annurev.iy.12.040194.001145 · Paper page
  3. Yewdell, 2003, Immunology, Science, 301, 1334, 10.1126/science.1089553 · doi:10.1126/science.1089553
  4. Boon, 1994, Tumor antigens recognized by T lymphocytes, Ann Rev Immunol, 12, 337, 10.1146/annurev.iy.12.040194.002005 · DOI · Paper page
  5. Vizler, 1999, Role of autoreactive CD8+ T cells in organ-specific autoimmune diseases: insight from transgenic mouse models, Immunol Rev, 169, 81, 10.1111/j.1600-065X.1999.tb01308.x · DOI
  6. Rocha, 2003, Effector mechanisms in transplant rejection, Immunol Rev, 196, 51, 10.1046/j.1600-065X.2003.00090.x · DOI · Paper page
  7. Goldrath, 1999, Selecting and maintaining a diverse T-cell repertoire, Nature, 402, 255, 10.1038/46218 · doi:10.1038/46218 · Paper page
  8. Marleau, 2005, T cell homeostasis in tolerance and immunity, J Leukoc Biol, 78, 575, 10.1189/jlb.0105050 · DOI · Paper page
  9. Vukmanovic, 2005, Self-peptide/MHC and TCR antagonism: physiological role and therapeutic potential, Cell Immunol, 233, 75, 10.1016/j.cellimm.2005.04.011 · DOI
  10. Vilches, 2002, KIR: diverse, rapidly evolving receptors of innate and adaptive immunity, Annu Rev Immunol, 20, 217, 10.1146/annurev.immunol.20.092501.134942 · DOI · Paper page
  11. Ziegler, 2005, Female choice and the MHC, Trends Immunol, 26, 496, 10.1016/j.it.2005.07.003 · DOI
  12. Perreault, 1998, Immunodominant minor histocompatibility antigens: the major ones, Immunol Today, 19, 69, 10.1016/S0167-5699(97)01185-7 · doi:10.1016/s0167-5699(97)01185-7
  13. Sugawara, 1987, A simple method to eliminate the antigenicity of surface class I MHC molecules from the membrane of viable cells by acid treatment at pH 3, J Immunol Methods, 100, 83, 10.1016/0022-1759(87)90175-X · DOI · Paper page
  14. Reche, 2002, Prediction of MHC class I binding peptides using profile motifs, Hum Immunol, 63, 701, 10.1016/S0198-8859(02)00432-9 · DOI · Paper page
  15. Day, 1995, Effect of TAP on the generation and intracellular trafficking of peptide-receptive major histocompatibility complex class I molecules, Immunity, 2, 137, 10.1016/S1074-7613(95)80014-X · DOI
  16. Rammensee, 1995, Chemistry of peptides associated with MHC class I and class II molecules, Curr Opin Immunol, 7, 85, 10.1016/0952-7915(95)80033-6 · DOI · Paper page
  17. Hickman, 2004, Toward a definition of self: proteomic evaluation of the class I peptide repertoire, J Immunol, 172, 2944, 10.4049/jimmunol.172.5.2944 · DOI · Paper page
  18. Urban, 1994, A subset of HLA-B27 molecules contains peptides much longer than nonamers, Proc Nat Acad Sci USA, 91, 1534, 10.1073/pnas.91.4.1534 · doi:10.1073/pnas.91.4.1534
  19. Olsen, 1994, A quantitative assay to measure the interaction between immunogenic peptides and purified class I major histocompatibility complex molecules, Eur J Immunol, 24, 385, 10.1002/eji.1830240218 · doi:10.1002/eji.1830240218
  20. Boisgerault, 1998, Alteration of HLA-B27 peptide presentation after infection of transfected murine L cells by Shigella flexneri, Infect Immun, 66, 4484, 10.1128/IAI.66.9.4484-4490.1998 · doi:10.1128/iai.66.9.4484-4490.1998
  21. Horig, 1999, Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria, J Immunol, 163, 4434, 10.4049/jimmunol.163.8.4434 · doi:10.4049/jimmunol.163.8.4434
  22. Stryhn, 2000, Longer peptide can be accommodated in the MHC class I binding site by a protrusion mechanism, Eur J Immunol, 30, 3089, 10.1002/1521-4141(200011)30:11<3089::AID-IMMU3089>3.0.CO;2-5 · doi:10.1002/1521-4141(200011)30:11<3089::aid-immu3089>3.0.co;2-5
  23. Probst-Kepper, 2001, An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes, J Exp Med, 193, 1189, 10.1084/jem.193.10.1189 · DOI
  24. Rammensee, 1995, MHC ligands and peptide motifs: first listing, Immunogenetics, 41, 178, 10.1007/BF00172063 · DOI · Paper page
  25. Rammensee, 1999, SYFPEITHI: database for MHC ligands and peptide motifs, Immunogenetics, 50, 213, 10.1007/s002510050595 · DOI · Paper page
  26. Kikuchi, 1996, Binding of nonamer peptides to three HLA-B51 molecules which differ by a single amino acid substitution in the A-pocket, Immunogenetics, 43, 268, 10.1007/BF02440994 · DOI
  27. Snyder, 1997, Two novel routes of transporter associated with antigen processing (TAP)-independent major histocompatibility complex class I antigen processing, J Exp Med, 1087, 10.1084/jem.186.7.1087 · DOI
  28. Snyder, 1998, Promiscuous liberation of MHC-class I-binding peptides from the C termini of membrane and soluble proteins in the secretory pathway, Eur J Immunol, 28, 1339, 10.1002/(SICI)1521-4141(199804)28:04<1339::AID-IMMU1339>3.0.CO;2-B · DOI
  29. Kubo, 1998, Residue 116 determines the C-terminal anchor residue of HLA-B*3501 and -B*5101 binding peptides but does not explain the general affinity difference, Immunogenetics, 47, 256, 10.1007/s002510050355 · doi:10.1007/s002510050355
  30. Maenaka, 2000, Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes, J Immunol, 165, 3260, 10.4049/jimmunol.165.6.3260 · DOI
  31. Ohno, 1982, Close association of HLA-Bw51 with Behcet’s disease, Arch Ophthalmol, 100, 1455, 10.1001/archopht.1982.01030040433013 · doi:10.1001/archopht.1982.01030040433013
  32. Mizuki, 2001, HLA class I genotyping including HLA-B*51 allele typing in the Iranian patients with Behcet’s diseas, Tissue Antigens, 57, 457, 10.1034/j.1399-0039.2001.057005457.x · doi:10.1034/j.1399-0039.2001.057005457.x
  33. Direskeneli, 2001, Behçet disease: infectious aetiology, mew autoantigens, and HLA-B51, Ann Rheum Dis, 60, 996, 10.1136/ard.60.11.996 · DOI · Paper page
  34. Verity, 2003, Behçet’s disease: from Hippocrates to the third millennium, Br J Ophtalmol, 87, 1175, 10.1136/bjo.87.9.1175 · doi:10.1136/bjo.87.9.1175
  35. Falk, 1995, Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behcet’s disease, Int Immunol, 7, 223, 10.1093/intimm/7.2.223 · DOI
  36. Direskeneli, 1999, Oligoclonal T cell expansions in patients with Behcet’s disease, Clin Exp Immunol, 117, 166, 10.1046/j.1365-2249.1999.00931.x · DOI
  37. Fairchild, 1996, Lowering the tone: mechanisms of immunodominance among epitopes with low affinity for MHC, Immunol Today, 17, 80, 10.1016/0167-5699(96)80584-6 · doi:10.1016/0167-5699(96)80584-6
  38. Vukmanovic, 2003, Could TCR antagonism explain associations between MHC genes and disease?, Trends Mol Med, 9, 139, 10.1016/S1471-4914(03)00029-7 · DOI

Cited by

See all 29

Metadata

Authors
Gebreselassie, D., Spiegel, H., & Vukmanovic, S.
Venue
Human Immunology
Publisher
Elsevier BV
Published
2006-11
Volume
67
Issue
11
Pages
894-906
ISSN
0198-8859
Cited by
29
References
1
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.